Meds, Mind, Body & Benefits > Questions About Treatment & Side Effects

FDA Grants Tentative Approval of a Three-Component AIDS Drug In Association with


The Food and Drug Administration (FDA) within the Department of Health and Human Services (HHS) today issued the first tentative approval for a three-ingredient fixed dose tablet for use as a stand-alone antiretroviral treatment for human immunodeficiency virus (HIV-1) infection in adults. The product (lamivudine-zidovudine-nevirapine tablet) contains the active ingredients in the widely used antiretroviral drugs Epivir (lamivudine), Retrovir (zidovudine), and Viramune (nevirapine).

Read more with other news

Click following


[0] Message Index

Go to full version